COVID-19 and the endocrine system: a comprehensive review on the theme

G Lisco, A De Tullio, A Stragapede… - Journal of clinical …, 2021 - mdpi.com
Background and aim. The review aimed to summarize advances in the topic of endocrine
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …

COVID-19 and the endocrine system: A review of the current information and misinformation

SA Mirza, AAE Sheikh, M Barbera, Z Ijaz… - Infectious Disease …, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) infection primarily involves the respiratory system but
has many noteworthy extra pulmonary manifestations as well. We write this review to …

COVID-19 infection and myocarditis: a state-of-the-art systematic review

V Jaiswal, Z Sarfraz, A Sarfraz… - Journal of Primary …, 2021 - journals.sagepub.com
Background: COVID-19 was initially considered to be a respiratory illness, but current
findings suggest that SARS-CoV-2 is increasingly expressed in cardiac myocytes as well …

Vasopressin and its analogues: from natural hormones to multitasking peptides

M Glavaš, A Gitlin-Domagalska, D Dębowski… - International journal of …, 2022 - mdpi.com
Human neurohormone vasopressin (AVP) is synthesized in overlapping regions in the
hypothalamus. It is mainly known for its vasoconstricting abilities, and it is responsible for the …

Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection

RA Misgar, A Rasool, AI Wani, MI Bashir - Journal of endocrinological …, 2021 - Springer
A novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has engulfed the world and has affected more than 151 …

Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature

LC Pezzaioli, E Gatta, F Bambini, P Facondo… - Frontiers in …, 2022 - frontiersin.org
Purpose The purpose of this study was to describe the current knowledge on the potential
endocrine adverse effects post-COVID-19 vaccines. Methods A PubMed/MEDLINE, Web of …

COVID-19 and hypopituitarism

S Frara, P Loli, A Allora, C Santini, L di Filippo… - Reviews in Endocrine …, 2022 - Springer
Besides the pulmonary manifestations caused by severe acute respiratory syndrome
(SARS) coronavirus 2 (SARS-CoV-2), an emerging endocrine phenotype, which can heavily …

Autoimmunity and immunodeficiency in severe SARS-CoV-2 infection and prolonged COVID-19

JV Garmendia, AH García, CV De Sanctis… - Current issues in …, 2022 - mdpi.com
SARS-CoV-2 causes the complex and heterogeneous illness known as COVID-19. The
disease primarily affects the respiratory system but can quickly become systemic, harming …

Pituitary and SARS CoV-2: an unremitting conundrum

C Capatina, C Poiana, M Fleseriu - Best Practice & Research Clinical …, 2023 - Elsevier
There is increased interest related to the impact of coronavirus disease 19 (COVID-19) on
the endocrine system and in particular on the pituitary gland. Over the course of the severe …

Central diabetes insipidus following immunization with BNT162b2 mRNA COVID-19 vaccine: A case report

B Bouça, M Roldão, P Bogalho, L Cerqueira… - Frontiers in …, 2022 - frontiersin.org
Introduction Cases of central diabetes insipidus (CDI) have been reported after COVID-19
infection, with hypophysitis being the most likely cause. COVID-19 vaccines potential …